Nationwide Implementation of a Population Management Dashboard for Monitoring Direct Oral Anticoagulants: Insights

Michael P Dorsch1,2,3, Charity S Chen4, Arthur L Allen5

  • 1College of Pharmacy (M.P.D.), University of Michigan, Ann Arbor.

Insights

A new dashboard improved direct oral anticoagulant prescribing in the Veterans Health Administration. The tool supported pharmacists in managing anticoagulation, showing rapid and sustained implementation across 94.7% of sites.

Area of Science:

  • Pharmacology
  • Health Informatics
  • Public Health

Background:

  • Direct oral anticoagulants (DOACs) are primary treatments for atrial fibrillation and venous thromboembolism.
  • Evidence-based prescribing of DOACs is complex due to varied dosing, renal function considerations, and drug interactions.
  • The Veterans Health Administration (VA) developed a population management dashboard to aid pharmacists in reviewing anticoagulant prescriptions.

Purpose of the Study:

  • To evaluate the nationwide implementation and adoption of a population health dashboard designed to support evidence-based prescribing of direct oral anticoagulants.
  • To assess the dashboard's reach, effectiveness, adoption, implementation, and maintenance within the Veterans Health Administration system.

Main Methods:

  • The study utilized login data from the population management dashboard to assess its implementation.
  • The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework guided the evaluation.
  • Data were collected between August 2016 and June 2020, covering 150 out of 164 VA sites.

Main Results:

  • The dashboard was adopted by 150/164 (91.5%) VA sites, with 142/150 (94.7%) achieving moderate to high adoption by June 2020.
  • Average unique users per site increased from 2.4 to 7.5 during the study period.
  • Sustained adoption (> 6 months) was achieved in 126/150 (84.0%) of sites.

Conclusions:

  • The population health dashboard was rapidly and successfully implemented and adopted nationwide within the VA system.
  • The tool effectively supported evidence-based anticoagulant prescribing.
  • Further research is needed to determine the clinical impact and to develop strategies for replicating this model in other healthcare systems.
Abstract

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
951
Integrated Healthcare System01:20

Integrated Healthcare System

An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
1.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
827